GovChime
Notice ID: a3117503ada54e8c91724b1d8ad25f0bCombined Synopsis/Solicitation

3D Bioprinting Station

Archived on September 21, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM UTC−04:00
Posted
August 26, 2022
Notice type
Combined Synopsis/Solicitation
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 25, 2026

Identifiers

Solicitation number
75N95022Q00443
Notice ID
a3117503ada54e8c91724b1d8ad25f0b

Description

The 3D Tissue Bioprinting Laboratory (3DTBL) at the National Center for Advancing Translational Sciences (NCATS) is producing and using engineered tissues as physiological relevant assay platforms for predictive drugs screening. There is a need to purchase a new bioprinter which will be used to increase the capabilities of the group to develop biofabricated tissue models, including neuronal circuits of addiction and pain (HEAL program), neuromuscular junction (NMJ) tissue for muscular dystrophy-related diseases (potential application for gene therapy, like congenital myasthenic syndrome (CMS) for PaVe-GT program), and pain (HEAL program), vascularized lung models for the Antiviral Pandemic Program (APP), and tissue for the two programs funded by the RFA-TR-21-015. The purpose of this acquisition is to acquire one (1) of Regenhu’s 3D Bioprinting Station model R-GEN 200 or Equal that meet all salient characteristics.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Contracting Officer

Primary Contact

Secondary Contact

Documents

No documents available.

Lifecycle

Solicitation:75N95022Q00443
  1. Combined Synopsis
  1. 2×
    Combined SynopsisCurrentAug 23, 2022

    3D Bioprinting Station

    Notice a3117503ada54e8c91724b1d8ad25f0b on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95022Q00443

Archive Date

Sep 21, 2022

Office Address

Bethesda, MD, 20892